Neurasthenia or Chronic Fatigue – Symptoms, Causes, and Management Methods
Neurasthenia is a complex neuropsychiatric condition characterized by persistent physical and mental asthenia, significantly impacting patients’ daily functioning. Initially described in the 19th century, this pathology continues to be of interest in contemporary psychiatry, especially in the context of increasing stress levels and lifestyle changes in modern society. This article provides a detailed analysis of neurasthenia, including essential aspects such as clinical presentation, etiopathogenic mechanisms, diagnostic criteria, and current therapeutic options, aiming to offer an integrated perspective on this disorder.
What is Neurasthenia?
Neurasthenia is a multifactorial neuropsychiatric disorder characterized by chronic fatigue, persistent physical and mental exhaustion, impaired concentration, and increased sensitivity to external stimuli. This condition was first described in 1869 by the American neurologist George Miller Beard, who associated it with the overexertion of the nervous system in the context of rapid industrial societal development. During the Victorian era, neurasthenia was considered a “disease of modern civilization,” frequently diagnosed among intellectuals and those exposed to prolonged stress. Although throughout the 20th century the concept transformed and was partially replaced by diagnoses such as chronic fatigue disorder or burnout syndrome, neurasthenia continues to be recognized in contemporary psychiatry, especially in Asia, where it remains a frequently used diagnosis.
Currently, neurasthenia is considered a disorder with a complex substrate, involving biological, psychological, and environmental factors. Among the pathophysiological mechanisms involved are dysfunctions of the hypothalamic-pituitary-adrenal (HPA) axis, changes in neurotransmitter levels such as serotonin and dopamine, neuroendocrine imbalances, and low-grade chronic inflammation. Nutritional deficiencies, particularly a lack of B vitamins, can also worsen symptoms, negatively impacting energy metabolism and central nervous system function.
The Role of B Vitamins in Combating Fatigue and Supporting the Nervous System
B vitamins are essential for neuronal health as they participate in neurotransmitter synthesis, energy metabolism, and the maintenance of neuroendocrine balance. Deficiencies in these vitamins can contribute to the onset of symptoms such as persistent fatigue, concentration difficulties, irritability, and sleep disturbances, all of which are common manifestations of neurasthenia.
[cta_produs style=”style_1″ product=”239641″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/03/Rolul-vitaminelor-B-in-combaterea-oboselii-si-sustinerea-sistemului-nervos.jpg”]
Premium Aronia Vitamin B-Complex is an advanced formula that combines all essential B vitamins – from B1, B2, B3, and B5 to B6, B7, B9, and B12 – along with Vitamin C, aronia juice, and apple juice, ingredients with a strong antioxidant and neuroprotective effect. This innovative combination offers optimal metabolic support, contributing to reduced fatigue and improved cognitive functions.
Unlike conventional supplements, this liquid, fast-absorbing formula provides superior bioavailability, making it easy to integrate into a daily routine. Furthermore, a single 15 ml dose per day ensures optimal intake for the nervous system, immunity, energy, and cardiovascular health.
Neurasthenia can significantly impact quality of life, but a multidisciplinary approach that includes stress management, lifestyle balance, and adequate supplementation with essential vitamins can make a major difference. Concurrently, Premium Aronia Vitamin B-Complex is the ideal solution for those seeking a concentrated source of essential nutrients in an advanced and effective formula designed to support both body and mind.
Types of Neurasthenia and Clinical Manifestations
In medical practice, neurasthenia is distinguished by two main clinical forms, each with specific characteristics that influence both diagnosis and therapeutic approach.
The **hypersthenic** form, also known as excitable neurasthenia, manifests with pronounced neurovegetative activation and excessive sensitivity to external stimuli. Patients exhibit increased irritability, accompanied by frequent episodes of anxiety and pronounced sensory hypersensitivity. Loud noises, bright lights, or even touch can become difficult to tolerate, triggering significant discomfort. In addition to this heightened reactivity, sleep disturbances are common, characterized by difficulty falling asleep and repeated nocturnal awakenings, leading to persistent exhaustion. Neurovegetative manifestations may also occur, such as palpitations, excessive sweating, and fine tremor of the extremities, all contributing to a general feeling of restlessness and inability to relax.
In contrast, the **hyposthenic** form, or depressive neurasthenia, is dominated by a state of profound lethargy and a marked decline in physical and mental energy. Patients experience progressive apathy, lack of motivation, and a tendency toward social withdrawal. Excessive daytime sleepiness becomes a frequent problem, along with a significant decrease in libido and cognitive difficulties manifested as what is often described as “brain fog.” Unlike the hypersthenic form, where symptoms are amplified by external stimuli, in hyposthenic neurasthenia, the patient experiences a generalized decrease in reactivity, and efforts to concentrate and perform intellectually become increasingly difficult.
Therefore, the symptomatology of neurasthenia varies depending on the subtype and can fluctuate in intensity depending on the level of effort exerted or other stressful factors. Most often, patients notice temporary symptom improvement with rest, but without an adequate therapeutic approach, the manifestations tend to reappear, significantly affecting quality of life.
How Does Chronic Fatigue Manifest, and What Mental and Emotional Symptoms Can Occur?
Photo source: Shutterstock.com
The chronic fatigue associated with neurasthenia is characterized by profound and persistent exhaustion that does not significantly improve even after prolonged periods of rest.
Firstly, patients experience a generalized sensation of muscle weakness. This occurs even in the absence of intense physical exertion. Routine activities can become demanding and difficult to sustain. This state of asthenia is often accompanied by diffuse muscle pain. The pain is described as a feeling of “heaviness” in the limbs. It is exacerbated by exertion and partially relieved by rest. Additionally, sleep disturbances are frequent, ranging from sleep-onset insomnia and frequent awakenings to fragmented and non-restorative sleep. These disturbances further worsen the state of physical and mental exhaustion.
Cognitively, neurasthenia leads to a significant reduction in concentration and attention capacity, with patients reporting difficulties in information processing and short-term memory impairments. This neurocognitive impairment translates into a state of confusion and mental slowness, often described by patients as “brain fog.” These cognitive dysfunctions can negatively impact intellectual and professional performance, leading to decreased efficiency in daily activities and increased difficulty in completing complex tasks.
Neurasthenia – Emotional Manifestations
Emotionally, neurasthenia manifests as increased irritability, emotional lability, and diffuse anxiety, characterized by a persistent feeling of restlessness and hyperreactivity to external stimuli. As the condition progresses, states of hopelessness, demotivation, and anhedonia may appear. These states can evolve into mild or moderate depressive episodes. Such emotional impairment, combined with persistent fatigue and cognitive disturbances, can foster a tendency towards social isolation, avoidance of interactions, and a significant reduction in quality of life.
Therefore, neurasthenia requires a multidisciplinary approach with interventions aimed at restoring neurochemical balance, improving cognitive function, and reducing the impact on mental health. Particular attention should also be paid to strategies for optimizing neuronal energy metabolism, where adequate intake of B vitamins, essential for optimal nervous system function, can play an important therapeutic role.
Causes and Risk Factors of Neurasthenia
As explained earlier, neurasthenia is a condition with multifactorial etiology, resulting from a complex interplay between neurobiological, psychological, and social factors. At the molecular level, dysfunctions in neurotransmitter systems are observed, particularly concerning serotonin, noradrenaline, and dopamine, which are involved in regulating mood, energy levels, and stress response. Imbalances in these neurotransmitters can contribute to the onset of characteristic symptoms such as chronic fatigue, apathy, and hypersensitivity to external stimuli.
Another important pathogenetic mechanism is the dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis, which plays a central role in regulating the body’s response to stress. Prolonged exposure to stressors leads to hyperactivation of this axis, resulting in abnormal cortisol levels, a hormone with direct effects on energy metabolism and nervous system function. In the long term, this deregulation can favor the onset of neuroendocrine exhaustion, a phenomenon frequently observed in severe cases of neurasthenia.
Psychological factors also contribute to individual vulnerability to this condition. Individuals with perfectionistic traits, Type A personality (competitive, performance-oriented, prone to stress), and low frustration tolerance have an increased risk of developing neurasthenia, especially under conditions of chronic overexertion. Traumatic life experiences, prolonged psychosocial stress, and difficulties adapting to major changes are also significant risk factors.
Genetically, there is evidence suggesting a hereditary predisposition, though the exact mechanisms are not fully understood. It is assumed that certain genetic variants regulating dopaminergic system activity and stress response can influence individual susceptibility to developing neurasthenia.
Certain population groups are more vulnerable to this condition, including professionals in demanding fields (such as medicine, education, and management), long-term caregivers, and individuals suffering from chronic medical conditions, particularly those associated with metabolic dysfunction and inflammatory disorders.
Diagnosing Neurasthenia
Diagnosing neurasthenia requires a detailed clinical evaluation that integrates thorough medical history, physical examination, and paraclinical investigations to rule out other conditions that could explain the patient’s symptoms.
The first step in the diagnostic process is a **detailed medical history**, which assesses the onset, duration, and evolution of symptoms, as well as triggering or aggravating factors such as chronic stress, lack of sleep, or excessive intellectual effort. The physician will analyze the impact of symptoms on daily functioning, professional performance, interpersonal relationships, and overall quality of life.
The physical examination is essential for excluding other organic causes of chronic fatigue and cognitive dysfunction, such as endocrine, neurological, or autoimmune diseases. Evaluation of the neurovegetative status is particularly important, as patients with neurasthenia may exhibit tachycardia, excessive sweating, fine tremor, and blood pressure instability, manifestations frequently correlated with neuroendocrine imbalances.
As neurasthenia does not have specific biological markers, paraclinical investigations are used to exclude other conditions that may mimic the symptomatology.
Routine analyses include:
- Complete blood count – to identify anemia that may contribute to fatigue.
- Thyroid tests (TSH, FT4, FT3) – to rule out hypothyroidism, a common cause of asthenia and cognitive disorders.
- Inflammatory markers (ESR, CRP) – to assess the presence of chronic inflammation.
- Vitamin B12 and folic acid levels – as deficiency of these nutrients can contribute to neurological dysfunction and persistent fatigue.
- Liver and kidney function tests – to rule out organic dysfunctions that may cause similar symptoms.
In cases where a deeper neurological or psychiatric component is suspected, imaging investigations may be indicated. These include brain Magnetic Resonance Imaging (MRI), especially to rule out neurological pathologies that can mimic neurasthenia symptoms. Additionally, if the patient presents severe sleep disorders, polysomnography may be performed. This is useful in diagnosing sleep apnea syndrome or other sleep disorders that may contribute to chronic exhaustion.
In contrast, to establish a diagnosis of neurasthenia, the presence of chronic fatigue, physical and mental weakness as central elements is required. These symptoms must have a duration of at least 3 to 6 months and a significant impact on daily activities. A crucial aspect in the diagnostic process is to exclude other medical and psychiatric conditions, including major depressive disorder, chronic fatigue syndrome, or somatoform disorders.
For a more objective evaluation, doctors may use standardized instruments such as:
- Neurasthenia Assessment Scale (NAS) – used to quantify symptom severity and assess therapeutic response.
- Multidimensional Fatigue Inventory (MFI) – used to analyze different components of fatigue, including physical, mental, and motivational fatigue.
Ultimately, an accurate diagnosis and a detailed understanding of etiological and risk factors allow for the development of a personalized treatment plan that targets both biological, psychological, and behavioral aspects, thus contributing to symptom improvement and enhanced patient quality of life.
Therapeutic Approaches in Neurasthenia Treatment
Managing neurasthenia involves an integrated therapeutic strategy tailored to the individual’s symptom profile and causal factors. Thus, the therapeutic approach must consider neurobiological and psychological aspects, as well as lifestyle and social influences that contribute to symptom maintenance.
In cases where symptoms are severe or significantly impair daily functioning, pharmacological treatment may be employed, under specialist supervision. Antidepressants are frequently prescribed to alleviate chronic fatigue, sleep disturbances, and anxiety symptoms. Examples include selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications help balance neurotransmitters involved in neurasthenia pathogenesis, positively impacting energy levels and emotional stability.
In certain situations, anxiolytics may be indicated for managing acute anxiety symptoms. However, their use should be limited to short periods due to the risk of tolerance and dependence. Supplements containing magnesium, B vitamins, and omega-3 fatty acids can offer metabolic and neuroprotective support, playing an important role in optimizing nervous system function.
In addition to pharmacological therapy, psychological interventions are fundamental to the recovery process. Cognitive-behavioral therapy (CBT) has proven effective in modifying dysfunctional thinking and behaviors that perpetuate symptoms, helping patients develop adaptive coping strategies. Concurrently, Acceptance and Commitment Therapy (ACT) encourages individuals to accept difficult emotional experiences and focus on engaging in actions that align with their personal values, thereby facilitating adaptation to stress and symptom reduction.
Only a multidisciplinary and personalized approach is essential for long-term recovery and prevention of symptom recurrence, combining pharmacological interventions, psychotherapy, and lifestyle optimization.
Lifestyle Modifications for Managing Neurasthenia
Photo source: Shutterstock.com
An effective approach to neurasthenia involves adopting significant lifestyle modifications aimed at optimizing energy levels, reducing stress, and improving daily functioning. By implementing tailored strategies, patients can achieve progressive symptom improvement and better resilience to stressors.
A useful concept in managing chronic fatigue is the Spoon Theory, which helps patients visualize and allocate their energy resources throughout the day. Essentially, each activity consumes a “spoon” from the daily energy reserve, and careful distribution of these resources can prevent exhaustion. Alternating periods of activity with rest, using careful planning of daily tasks, prioritizing essential activities, and avoiding overexertion are crucial measures to prevent episodes of severe asthenia.
First and foremost, quality sleep is essential for nervous system regeneration and neuroendocrine function balance. Maintaining a regular sleep schedule, with fixed bedtime and wake-up times, helps synchronize the circadian rhythm and improve sleep efficiency.
Optimizing the Sleep Environment
The sleep environment should be conducive to relaxation by maintaining a comfortable ambient temperature, reducing noise, and eliminating sources of excessive artificial light. Limiting screen exposure at least one hour before bedtime is recommended, as blue light interferes with melatonin secretion, a hormone essential for initiating sleep.
A balanced diet plays a crucial role in regulating energy levels and supporting cognitive function. A diet rich in antioxidants from colorful fruits and vegetables is recommended, as these contribute to reducing oxidative stress and systemic inflammation.
Quality proteins from sources such as lean meat, fish, eggs, and legumes are necessary for the synthesis of neurotransmitters involved in mood and energy regulation. Complex carbohydrates, like whole grains, quinoa, and legumes, provide a gradual release of energy, preventing hypoglycemia and mood swings.
The Importance of Hydration for Cognitive Function
Adequate hydration is also fundamental for maintaining optimal cognitive function. Even mild dehydration can exacerbate feelings of fatigue, concentration difficulties, and headaches. Regular water consumption is recommended, and excessive intake of caffeine and energy drinks, which can worsen long-term exhaustion, should be avoided.
Lastly, regular physical exercise, adapted to individual tolerance levels, can have significant beneficial effects on energy metabolism, mood, and cognitive function. Physical activities should be introduced progressively to avoid overexertion and worsening fatigue.
Initially, short sessions of light movement, such as daily walks or stretching, are most suitable. As energy levels increase, patients can incorporate low-impact activities like swimming, which improves blood circulation, mobility, and neurovegetative balance.
The Impact of Neurasthenia on Quality of Life and Social Relationships
Neurasthenia can have significant consequences on autonomy, professional functioning, and interpersonal relationships, thus profoundly affecting quality of life.
Chronic fatigue and physical weakness limit the ability to perform daily activities independently, which can lead to increased dependence on others for basic tasks. This loss of independence contributes to a diminished self-image and self-confidence, generating frustration and a sense of helplessness.
Professionally, cognitive difficulties can impact work productivity and efficiency. These include reduced concentration capacity and lower stress tolerance. This functional decline can lead to frequent absenteeism, diminished advancement opportunities, and, in some cases, necessitate a change in the pace or nature of professional activity.
In interpersonal relationships, neurasthenia can create tension in couples, as the partner may feel the additional pressure of taking over daily tasks and responsibilities. Relationships with children can be affected by the difficulty in keeping up with their energy and needs. Social interactions may become increasingly limited due to reduced availability for group activities or social events.
In other words, managing these challenges involves open communication with loved ones, establishing realistic boundaries, and prioritizing essential activities. Maintaining social connections can be facilitated by adapting interactions, such as virtual meetings or activities that do not require high energy expenditure.
Strategies and Recommendations for Preventing Neurasthenia
Preventing neurasthenia involves implementing proactive stress management and lifestyle optimization strategies. Advanced mindfulness practices, such as “body scan” and “mindful walking,” facilitate the integration of awareness into daily routines. Gradual exposure to stress, under specialized guidance, contributes to developing psychological resilience.
Adapting lifestyle according to individual chronobiology improves metabolic and neurocognitive efficiency. Adjusting sleep schedules and daily activities based on personal circadian rhythms optimizes bodily recovery. Personalizing diet based on nutrigenetic analysis can ensure optimal intake of nutrients essential for neurological health.
Developing emotional intelligence through techniques like “affect labeling” and “cognitive reappraisal” facilitates emotional regulation and reduces the impact of stress. Self-compassion and empathy practices contribute to stabilizing the hypothalamic-pituitary-adrenal axis, reducing cortisol levels, and improving emotional resilience.
In the professional environment, applying the “deep work” principle, by alternating blocks of intense concentration with recovery periods, supports cognitive efficiency and prevents mental exhaustion.
What Research Directions Promise to Improve the Understanding and Treatment of Fatigue Symptoms?
Recent research in the field of neurasthenia is advancing rapidly, offering new insights into pathogenetic mechanisms and therapeutic strategies. The use of advanced neuroimaging technologies, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), allows for the investigation of subtle changes in brain activity and connectivity in patients with neurasthenia. Such techniques can contribute to identifying neurophysiological biomarkers, thus facilitating early diagnosis and personalized treatment.
Genetically, genome-wide association studies (GWAS) and epigenetic research explore genetic variations associated with neurasthenia susceptibility. Identifying these factors could lead to the development of predictive tests and individualized therapies based on each patient’s specific genetic profile.
Another promising direction is the study of the gut microbiome, due to the close link between the gut-brain axis and mental health. Metagenomic analyses of gut microbiota in patients with neurasthenia investigate correlations between microbial imbalances and symptom severity, paving the way for new therapeutic strategies based on microbiota modulation through probiotics, prebiotics, and dietary therapy.
Chronic Inflammation and Neurasthenia
Low-grade chronic inflammation is another area of interest, with current research examining the role of pro-inflammatory cytokines in neurasthenia. Immunotherapy and selective anti-inflammatory compounds are being tested for modulating the immune response and reducing chronic fatigue associated with this condition. Monoclonal antibodies, used to target specific inflammatory molecules, are in experimental phases as potential therapeutic solutions.
Neuromodulation technologies, such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), are being evaluated for their ability to alleviate fatigue, improve cognitive function, and regulate the activity of neural circuits involved in neurasthenia. These minimally invasive methods may represent a promising alternative for patients who do not respond to conventional treatments.
In the context of medicine’s digitalization, the development of telemedicine solutions and digital therapies is redefining treatment accessibility. AI-based mobile applications that monitor symptoms in real-time and provide personalized interventions are undergoing clinical validation. These platforms have the potential to optimize neurasthenia management by offering continuous and tailored support to individual patient needs.
Through these advancements, research in neurasthenia is moving towards a personalized approach that will enable more accurate diagnosis, tailored therapeutic interventions, and improved quality of life for patients affected by this complex condition.
Neurasthenia remains a significant challenge in mental health, with profound implications for patients’ quality of life. A multidisciplinary approach, combining pharmacological treatment with psychotherapy and lifestyle modifications, offers the best chance for effective symptom management. Furthermore, ongoing research promises to bring new perspectives and personalized therapeutic options.
Ultimately, increased public awareness of neurasthenia can contribute to reducing stigma and improving social support for affected individuals.
References:
1. Watanabe, Y., & Kuratsune, H. (2006). Brain science on chronic fatigue. Japan Medical Association Journal, 49(1), 19-26;
2. Natelson, B. H. (2019). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Gulf War Illness: Medically Unexplained Symptoms in Veterans. Frontiers in Neurology, 10, 1008;
3. Maes, M., & Twisk, F. N. (2010). Chronic fatigue syndrome: Harvey and Wessely’s (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Medicine, 8, 35;
4. Fukuda, S., Nojima, J., Motoki, Y., Yamaguti, K., Nakatomi, Y., Okawa, N., … & Watanabe, Y. (2016). A potential biomarker for fatigue: Oxidative stress and anti-oxidative activity. Biological Psychology, 118, 88-93;
5. Montoya, J. G., Holmes, T. H., Anderson, J. N., Maecker, H. T., Rosenberg-Hasson, Y., Valencia, I. J., … & Davis, M. M. (2017). Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proceedings of the National Academy of Sciences, 114(34), E7150-E7158;
Photo source: Shutterstock.com